Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.

Cedric Follonier Elena TessitoreSandra HandgraafDavid CarballoMaëlle AchardAntoinette Pechère-BertschiFrançois MachFrançois R HerrmannFrançois R Girardin

Published in: PloS one (2022)

In hospitalized and unvaccinated patients with COVID-19, there was no detrimental association of the prehospital use of any regular cardiovascular medication with in-hospital death, and these therapies should be continued as recommended.

Keyphrases

healthcare
adverse drug
acute care
cardiac arrest
stem cells
emergency department
mesenchymal stem cells
trauma patients
cell therapy
emergency medical
replacement therapy